Cargando…

Pancreatic β‐cell fate in subjects with COVID‐19

Two recent reports denoted the potential of SARS‐CoV‐2 to directly infect β‐cells and the possible fate of β‐cells under COVID‐19. The fight against SARS‐CoV‐2 will continue to develop more effective therapeutic strategies for diabetes. [Image: see text]

Detalles Bibliográficos
Autor principal: Shirakawa, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8668054/
https://www.ncbi.nlm.nih.gov/pubmed/34529355
http://dx.doi.org/10.1111/jdi.13671
_version_ 1784614488942575616
author Shirakawa, Jun
author_facet Shirakawa, Jun
author_sort Shirakawa, Jun
collection PubMed
description Two recent reports denoted the potential of SARS‐CoV‐2 to directly infect β‐cells and the possible fate of β‐cells under COVID‐19. The fight against SARS‐CoV‐2 will continue to develop more effective therapeutic strategies for diabetes. [Image: see text]
format Online
Article
Text
id pubmed-8668054
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-86680542021-12-21 Pancreatic β‐cell fate in subjects with COVID‐19 Shirakawa, Jun J Diabetes Investig Commentaries Two recent reports denoted the potential of SARS‐CoV‐2 to directly infect β‐cells and the possible fate of β‐cells under COVID‐19. The fight against SARS‐CoV‐2 will continue to develop more effective therapeutic strategies for diabetes. [Image: see text] John Wiley and Sons Inc. 2021-09-27 2021-12 /pmc/articles/PMC8668054/ /pubmed/34529355 http://dx.doi.org/10.1111/jdi.13671 Text en © 2021 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Commentaries
Shirakawa, Jun
Pancreatic β‐cell fate in subjects with COVID‐19
title Pancreatic β‐cell fate in subjects with COVID‐19
title_full Pancreatic β‐cell fate in subjects with COVID‐19
title_fullStr Pancreatic β‐cell fate in subjects with COVID‐19
title_full_unstemmed Pancreatic β‐cell fate in subjects with COVID‐19
title_short Pancreatic β‐cell fate in subjects with COVID‐19
title_sort pancreatic β‐cell fate in subjects with covid‐19
topic Commentaries
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8668054/
https://www.ncbi.nlm.nih.gov/pubmed/34529355
http://dx.doi.org/10.1111/jdi.13671
work_keys_str_mv AT shirakawajun pancreaticbcellfateinsubjectswithcovid19